Results 261 to 270 of about 4,938,261 (300)

Renal extramedullary hematopoiesis as an epiphenomenon of bone marrow dysfunction in a patient with primary myelofibrosis: A rare case report. [PDF]

Radiol Case Rep
Ini' C, Foti PV, Duminuco A, Farina R, Clemenza M, Tiralongo F, David E, Palmucci S, Palumbo GA, Basile A.   +9 more
europepmc   +1 more source

Real-world outcomes with fedratinib therapy in patients who discontinued ruxolitinib for primary myelofibrosis. [PDF]

Future Oncol
Passamonti F, Lou Y, Chevli M, Abraham P.   +3 more
europepmc   +1 more source

Primary Myelofibrosis

Handbook of Hematologic Malignancies, 2018
Initially, most people with primary myelofibrosis have no signs or symptoms. Eventually, fibrosis can lead to a reduction in the number of red blood cells, white blood cells, and platelets.
John Mascarenhas, Vesna Najfeld, Marina Kremyanskaya, Alla Keyzner, Mohamed E. Salama, Ronald Hoffman   +5 more
semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Data‐driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis

European Journal of Haematology, 2021
Hydroxyurea (HU) treatment of patients with essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF) (MPNs) normalizes elevated blood cell counts within weeks in the large majority of patients.
M. J. Dam, R. Pedersen, T. Knudsen, Morten Andersen, V. Skov, L. Kjaer, H. Hasselbalch, J. Ottesen   +7 more
semanticscholar   +1 more source

Prognostication in Primary Myelofibrosis

Current Hematologic Malignancy Reports, 2011
Primary myelofibrosis (PMF) is a Philadelphia chromosome-negative chronic myeloproliferative neoplasm usually affecting elderly people. Median survival currently approaches 6 years, with a few patients surviving more than 20 years but others dying soon after diagnosis. In 10% to 20% of patients, PMF evolves into acute leukemia.
Francisco, Cervantes, Arturo, Pereira
openaire   +2 more sources

Primary myelofibrosis

2010
Myelofibrosis is a reactive process common to many malignant and benign disorders. Primary myelofibrosis is a chronic myeloproliferative disorder of unknown aetiology that involves a multipotent haemopoietic progenitor cell and results in abnormalities in red cell, white cell, and platelet production in association with marrow fibrosis and ...
Yuranga Weerakkody, Rohit Sharma, Evangeline Collins   +2 more
openaire   +2 more sources

Primary hypertrophic osteoarthropathy with myelofibrosis

Rheumatology International, 2007
Primary hypertrophic osteoarthropathy or pachydermoperiostosis is a rare congenital disease characterized by clubbing of the fingers, periostitis of the distal long bones, and hypertrophic skin changes (pachydermia) including thick folds in the skin of the face, forehead, scalp and extremities, and also joint pain.
Massoud, Saghafi, Azita, Azarian, Najmeh, Nohesara   +2 more
openaire   +2 more sources

Renal complications of primary myelofibrosis

Leukemia & Lymphoma, 2018
Primary myelofibrosis (PMF) is a disease of the elderly, with a median age at diagnosis of 71 years.
Paolo, Strati, William F, Glass, Maen, Abdelrahim, Umut, Selamet, Amanda, Tchakarov, Biruh T, Workeneh, Srdan, Verstovsek, Ala, Abudayyeh   +7 more
openaire   +2 more sources